Ruotsi A, Hypén M, Rekonen A, Oka M
Ann Rheum Dis. 1979 Feb;38(1):45-7. doi: 10.1136/ard.38.1.45.
Erbium--169 was compared with triamcinolone hexacetonide in the topical treatment of 32 patients suffering from rheumatoid arthritis. Erbium--169 was injected into 83 and triamcinolone hexacetonide into 54 proximal interphalangeal or metacarpophalangeal joints. Both treatments produced alleviation of joint pain and swelling and improvement of grip strength. At every check-up (1--18 months) the percentage of remissions was higher after triamcinolone hexacetonide injection than after erbium--169. The difference was significant at 1, 3, and 6 months.
将铒-169与己酸曲安奈德用于32例类风湿性关节炎患者的局部治疗并进行比较。向83个近端指间关节或掌指关节注射铒-169,向54个关节注射己酸曲安奈德。两种治疗均使关节疼痛和肿胀减轻,握力改善。在每次检查(1至18个月)时,己酸曲安奈德注射后缓解的百分比高于铒-169注射后。在1、3和6个月时差异显著。